Anthem Biosciences has reported result for first quarter ended June 30, 2025 (Q1FY26).
The company has reported 73.82% rise in its net profit at Rs 148.34 crore for the quarter ended June 30, 2025 as compared to Rs 85.34 crore for the same quarter in the previous year. The total income of the company increased by 58.03% at Rs 565.74 crore for Q1FY26 as compared to Rs 357.99 crore for the corresponding quarter previous year.
On consolidated basis, the company has reported 64.83% rise in its net profit at Rs 135.79 crore for Q1FY26 as compared to Rs 82.38 crore for the same quarter in the previous year. The total income of the company increased by 57.25% at Rs 563.02 crore for Q1FY26 as compared to Rs 358.05 crore for the corresponding quarter previous year.